Bench-To-Bedside Lag Time in Drug Development

ISEF Category: Translational Medical Science

Subcategory: Other  ·  Difficulty: Advanced  ·  Setup: Home Setup  ·  Time: Full Year

The Hook

Some drugs reach patients fast, while others take decades. That gap can hide in plain sight inside papers, trial records, and approval dates. You can measure it like a race, then ask why some fields cross the finish line sooner than others.

What Is It?

This project looks at how long it takes for a research idea to move from the first paper that explains a mechanism to FDA approval. That time gap is often called translation lag. Think of it like a relay race. The lab paper starts the race, clinical trials pass the baton, and approval ends it.

You are not testing a medicine in a patient. You are studying the path the idea takes. PubMed can help you find the first mechanism-of-action paper, and ClinicalTrials.gov can help you track early human testing. FDA approval records can give you the endpoint. Your job is to build a timeline for each therapy and compare those timelines across disease areas.

This kind of project mixes biology, data analysis, and research methods. You will learn how to define a search rule, clean messy records, and turn dates into a median lag time. You can also test which features, like drug type, disease area, or trial phase, seem linked to faster translation.

Why This Is a Good Topic

This is a strong science fair topic because it starts with public data, not a wet lab. You can test a clear question, compare categories, and use real biomedical records instead of guessing. It connects to a real problem too, because slow translation can delay treatments for patients. You can learn literature search skills, database work, basic statistics, and how to think like a biomedical researcher.

Research Questions

• How does therapeutic area affect the median years from first mechanism-of-action paper to FDA approval?
• What is the effect of drug modality, such as small molecule versus biologic, on translation lag time?
• Does the number of clinical trial phases before approval predict shorter or longer lag time?
• To what extent does the year of first publication predict faster approval in recent decades?
• Which therapeutic areas have the highest share of projects that never reach FDA approval?
• How does the time from first publication to first registered clinical trial vary across disease areas?
• What is the effect of orphan disease status on the time from mechanism paper to approval?

Basic Materials

• Computer with internet access.
• PubMed account or browser access to PubMed.
• ClinicalTrials.gov access.
• FDA drug approval database or Drugs@FDA records.
• Spreadsheet software such as Google Sheets or Excel.
• Reference manager such as Zotero.
• Data dictionary or codebook template.
• Notebook for search rules and inclusion criteria.

Advanced Materials

• Computer with internet access.
• Python with pandas for data cleaning and analysis.
• R with tidyverse and survival analysis packages.
• PubMed API access through NCBI E-utilities.
• ClinicalTrials.gov API or downloadable records.
• FDA Drugs@FDA records.
• PubChem for drug identity matching.
• Statistical software for regression and survival models.
• Data visualization software such as Tableau Public or R ggplot2.

Software & Tools

• PubMed: Finds the first mechanism-of-action papers and related review articles for each therapy.
• ClinicalTrials.gov: Tracks trial start dates, phases, and sponsor information for candidate therapies.
• Drugs@FDA: Confirms approval dates and product names from the FDA record.
• Zotero: Organizes papers, stores citations, and helps you track search decisions.
• Python: Cleans timelines, calculates lag times, and runs regression or survival analysis.

Experiment Steps

1. Define your unit of analysis, such as one drug, one biologic, or one therapeutic program, and decide how you will identify the first mechanism paper.
2. Build inclusion rules that say which records count, which count as duplicates, and which records you will exclude.
3. Create a timeline for each case using publication date, first registered trial date, and FDA approval date.
4. Choose the main outcome, such as years from first paper to approval, and decide how you will handle missing approvals or abandoned programs.
5. Plan your comparison groups, such as cancer, rare disease, or autoimmune disease, and choose one statistical test for group differences.
6. Pre-register your search logic and analysis plan in a lab notebook or project log before you collect the full dataset.

Common Pitfalls

• Using a broad search string that mixes up review articles, mechanistic papers, and unrelated preclinical studies.
• Matching the wrong paper to a drug because the same target, pathway, or compound name appears in many places.
• Treating first clinical trial date as approval date, which collapses two different milestones into one.
• Ignoring abandoned programs, which makes the fastest-successful cases look more common than they are.
• Comparing raw dates without normalizing for therapeutic area, which can hide big differences in disease burden, trial length, and regulatory pathway.

What Makes This Competitive

A strong version of this project goes beyond a simple average lag time. You would need careful rules for finding the true first mechanism paper, a clean way to match papers to trials and approvals, and a plan for missing or abandoned programs. Strong statistics matter too, especially if you compare disease areas or test predictors with regression or survival analysis. A top project can also ask whether translation speed has changed over time or differs by drug type in a way that has not been mapped clearly before.

Project Variations

• Compare translation lag time for cancer therapies versus rare disease therapies using the same search rules.
• Focus only on biologics or only on small molecules, then test whether one class moves faster from paper to approval.
• Measure the gap between first mechanism paper and first registered clinical trial instead of final FDA approval.

Learn More

• PubMed: Search for review articles on translational research, drug development timelines, and bibliometric methods using the PubMed database.
• ClinicalTrials.gov: Read trial records and search by condition, intervention, sponsor, and phase in the NIH-run registry.
• Drugs@FDA: Find approval letters, labels, and approval history for U.S. drug products on the FDA site.
• NIH Office of Extramural Research: Read guidance on human subjects, research integrity, and responsible data handling on the NIH website.
• MIT OpenCourseWare, Introduction to Probability and Statistics: Review core statistics for comparing groups and modeling time-to-event data.
• Nature Reviews Drug Discovery: Search for review articles on drug development timelines and translational bottlenecks through your school library or open abstracts.